NEW YORK (GenomeWeb) – Beta-blocker treatment may undo some of the gene expression changes that occur in heart failure, according to a new study.

Beta-blockers are commonly used to treat cardiac conditions, including heart failure, and they target myocyte enhancer factor 2 (MEF2) proteins, which are involved in cardiac remodeling.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.